427 related articles for article (PubMed ID: 26402114)
1. Bexarotene Promotes Cholesterol Efflux and Restricts Apical-to-Basolateral Transport of Amyloid-β Peptides in an In Vitro Model of the Human Blood-Brain Barrier.
Kuntz M; Candela P; Saint-Pol J; Lamartinière Y; Boucau MC; Sevin E; Fenart L; Gosselet F
J Alzheimers Dis; 2015; 48(3):849-62. PubMed ID: 26402114
[TBL] [Abstract][Full Text] [Related]
2. Astaxanthin exerts protective effects similar to bexarotene in Alzheimer's disease by modulating amyloid-beta and cholesterol homeostasis in blood-brain barrier endothelial cells.
Fanaee-Danesh E; Gali CC; Tadic J; Zandl-Lang M; Carmen Kober A; Agujetas VR; de Dios C; Tam-Amersdorfer C; Stracke A; Albrecher NM; Manavalan APC; Reiter M; Sun Y; Colell A; Madeo F; Malle E; Panzenboeck U
Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2224-2245. PubMed ID: 31055081
[TBL] [Abstract][Full Text] [Related]
3. Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).
Do TM; Dodacki A; Alata W; Calon F; Nicolic S; Scherrmann JM; Farinotti R; Bourasset F
J Alzheimers Dis; 2016; 49(2):287-300. PubMed ID: 26484906
[TBL] [Abstract][Full Text] [Related]
4. Oxysterols decrease apical-to-basolateral transport of Aß peptides via an ABCB1-mediated process in an in vitro Blood-brain barrier model constituted of bovine brain capillary endothelial cells.
Saint-Pol J; Candela P; Boucau MC; Fenart L; Gosselet F
Brain Res; 2013 Jun; 1517():1-15. PubMed ID: 23603412
[TBL] [Abstract][Full Text] [Related]
5. ABCA7 Downregulation Modifies Cellular Cholesterol Homeostasis and Decreases Amyloid-β Peptide Efflux in an in vitro Model of the Blood-Brain Barrier.
Lamartinière Y; Boucau MC; Dehouck L; Krohn M; Pahnke J; Candela P; Gosselet F; Fenart L
J Alzheimers Dis; 2018; 64(4):1195-1211. PubMed ID: 30010117
[TBL] [Abstract][Full Text] [Related]
6. ABCA1 is Necessary for Bexarotene-Mediated Clearance of Soluble Amyloid Beta from the Hippocampus of APP/PS1 Mice.
Corona AW; Kodoma N; Casali BT; Landreth GE
J Neuroimmune Pharmacol; 2016 Mar; 11(1):61-72. PubMed ID: 26175148
[TBL] [Abstract][Full Text] [Related]
7. Apical-to-basolateral transport of amyloid-β peptides through blood-brain barrier cells is mediated by the receptor for advanced glycation end-products and is restricted by P-glycoprotein.
Candela P; Gosselet F; Saint-Pol J; Sevin E; Boucau MC; Boulanger E; Cecchelli R; Fenart L
J Alzheimers Dis; 2010; 22(3):849-59. PubMed ID: 20858979
[TBL] [Abstract][Full Text] [Related]
8. Reversal of apoE4-driven brain pathology and behavioral deficits by bexarotene.
Boehm-Cagan A; Michaelson DM
J Neurosci; 2014 May; 34(21):7293-301. PubMed ID: 24849361
[TBL] [Abstract][Full Text] [Related]
9. Retinoic acid isomers facilitate apolipoprotein E production and lipidation in astrocytes through the retinoid X receptor/retinoic acid receptor pathway.
Zhao J; Fu Y; Liu CC; Shinohara M; Nielsen HM; Dong Q; Kanekiyo T; Bu G
J Biol Chem; 2014 Apr; 289(16):11282-11292. PubMed ID: 24599963
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of the retinoid X receptor facilitates beta-amyloid clearance across the blood-brain barrier.
Bachmeier C; Beaulieu-Abdelahad D; Crawford F; Mullan M; Paris D
J Mol Neurosci; 2013 Feb; 49(2):270-6. PubMed ID: 22890420
[TBL] [Abstract][Full Text] [Related]
11. Amyloid-β pathology and APOE genotype modulate retinoid X receptor agonist activity in vivo.
Tai LM; Koster KP; Luo J; Lee SH; Wang YT; Collins NC; Ben Aissa M; Thatcher GRJ; LaDu MJ
J Biol Chem; 2014 Oct; 289(44):30538-30555. PubMed ID: 25217640
[TBL] [Abstract][Full Text] [Related]
12. Bexarotene reduces blood-brain barrier permeability in cerebral ischemia-reperfusion injured rats.
Xu L; Cao F; Xu F; He B; Dong Z
PLoS One; 2015; 10(4):e0122744. PubMed ID: 25844636
[TBL] [Abstract][Full Text] [Related]
13. ABCG2- and ABCG4-mediated efflux of amyloid-β peptide 1-40 at the mouse blood-brain barrier.
Do TM; Noel-Hudson MS; Ribes S; Besengez C; Smirnova M; Cisternino S; Buyse M; Calon F; Chimini G; Chacun H; Scherrmann JM; Farinotti R; Bourasset F
J Alzheimers Dis; 2012; 30(1):155-66. PubMed ID: 22391220
[TBL] [Abstract][Full Text] [Related]
14. RNA-sequencing reveals transcriptional up-regulation of Trem2 in response to bexarotene treatment.
Lefterov I; Schug J; Mounier A; Nam KN; Fitz NF; Koldamova R
Neurobiol Dis; 2015 Oct; 82():132-140. PubMed ID: 26071899
[TBL] [Abstract][Full Text] [Related]
15. A multifaceted role for apoE in the clearance of beta-amyloid across the blood-brain barrier.
Bachmeier C; Paris D; Beaulieu-Abdelahad D; Mouzon B; Mullan M; Crawford F
Neurodegener Dis; 2013; 11(1):13-21. PubMed ID: 22572854
[TBL] [Abstract][Full Text] [Related]
16. 1,25-Dihydroxyvitamin D3 regulates expression of LRP1 and RAGE in vitro and in vivo, enhancing Aβ1-40 brain-to-blood efflux and peripheral uptake transport.
Guo YX; He LY; Zhang M; Wang F; Liu F; Peng WX
Neuroscience; 2016 May; 322():28-38. PubMed ID: 26820600
[TBL] [Abstract][Full Text] [Related]
17. Modulation of Amyloid-β1-40 Transport by ApoA1 and ApoJ Across an in vitro Model of the Blood-Brain Barrier.
Merino-Zamorano C; Fernández-de Retana S; Montañola A; Batlle A; Saint-Pol J; Mysiorek C; Gosselet F; Montaner J; Hernández-Guillamon M
J Alzheimers Dis; 2016 May; 53(2):677-91. PubMed ID: 27232214
[TBL] [Abstract][Full Text] [Related]
18. Possible Molecular Interactions of Bexarotene - A Retinoid Drug and Alzheimer's Aβ Peptide: A Docking Study.
Mirza Z; Beg MA
Curr Alzheimer Res; 2017; 14(3):327-334. PubMed ID: 27842487
[TBL] [Abstract][Full Text] [Related]
19. Brain pericytes ABCA1 expression mediates cholesterol efflux but not cellular amyloid-β peptide accumulation.
Saint-Pol J; Vandenhaute E; Boucau MC; Candela P; Dehouck L; Cecchelli R; Dehouck MP; Fenart L; Gosselet F
J Alzheimers Dis; 2012; 30(3):489-503. PubMed ID: 22433669
[TBL] [Abstract][Full Text] [Related]
20. Oleocanthal enhances amyloid-β clearance from the brains of TgSwDI mice and in vitro across a human blood-brain barrier model.
Qosa H; Batarseh YS; Mohyeldin MM; El Sayed KA; Keller JN; Kaddoumi A
ACS Chem Neurosci; 2015 Nov; 6(11):1849-59. PubMed ID: 26348065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
